TT International Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,000
Closed -$999K 48
2025
Q3
$999K Hold
9,000
0.19% 35
2025
Q2
$998K Buy
9,000
+4,325
+93% +$460K 0.19% 41
2025
Q1
$524K Hold
4,675
0.08% 51
2024
Q4
$432K Sell
4,675
-10,325
-69% -$930K 0.06% 50
2024
Q3
$1.26M Buy
+15,000
New +$1.14M 0.15% 48
2020
Q2
$3.13M Sell
40,717
-36,212
-47% -$2.78M 0.21% 32
2020
Q1
$5.75M Buy
+76,929
New +$5.32M 0.56% 24

Other funds holding GILD

TT International Asset Management's GILD Position: Q4 2025 in Review

TT International Asset Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 9,000 shares — an estimated $999K sold.

TT International Asset Management first reported a position in GILD in Q1 2020 and held it in 7 quarters. The position peaked at $5.75M in Q1 2020. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

  • TT International Asset Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
  • TT International Asset Management sold 9,000 Gilead Sciences shares in Q4 2025, an estimated $999K.
  • TT International Asset Management first reported a position in Gilead Sciences in Q1 2020 and held it in 7 quarters.
  • TT International Asset Management's Gilead Sciences position peaked at $5.75M in Q1 2020.
  • 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on TT International Asset Management's 13F filing for Q4 2025, filed 23 Jan 2026.